Cisplatin

Common brands: Vepesid, Avopef, Etoposide, Gemcitabine, Dexamethasone 1.5 Mg

Top reporter: Accord Healthcare Inc.

Platinum-based Drug [EPC]Topoisomerase Inhibitor [EPC]Nucleoside Metabolic Inhibitor [EPC]Corticosteroid [EPC]Alkylating Drug [EPC]
76,216
Total Reports
35,855
Serious Reports
14,729
Death Reports
30
Reported Reactions
Death Report Ratio: High (19.33%)

Patient Demographics

Male
37,967
Female
25,084

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Cisplatin.

# Reaction Reports % of Total
1 OFF LABEL USE 5,721
6.6%
2 NAUSEA 5,373
6.2%
3 NEUTROPENIA 4,790
5.6%
4 DISEASE PROGRESSION 4,590
5.3%
5 VOMITING 4,520
5.2%
6 FEBRILE NEUTROPENIA 4,499
5.2%
7 ANAEMIA 3,966
4.6%
8 DIARRHOEA 3,722
4.3%
9 THROMBOCYTOPENIA 3,710
4.3%
10 PYREXIA 3,354
3.9%
11 DRUG INEFFECTIVE 3,248
3.8%
12 MALIGNANT NEOPLASM PROGRESSION 3,162
3.7%
13 DEATH 2,695
3.1%
14 MYELOSUPPRESSION 2,486
2.9%
15 FATIGUE 2,478
2.9%
16 DEHYDRATION 2,455
2.8%
17 PNEUMONIA 2,328
2.7%
18 SEPSIS 2,069
2.4%
19 ASTHENIA 2,018
2.3%
20 DYSPNOEA 1,920
2.2%
21 MUCOSAL INFLAMMATION 1,905
2.2%
22 PANCYTOPENIA 1,859
2.2%
23 DECREASED APPETITE 1,843
2.1%
24 ACUTE KIDNEY INJURY 1,804
2.1%
25 PLATELET COUNT DECREASED 1,715
2.0%
26 WHITE BLOOD CELL COUNT DECREASED 1,687
2.0%
27 LEUKOPENIA 1,641
1.9%
28 PULMONARY EMBOLISM 1,564
1.8%
29 PRODUCT USE IN UNAPPROVED INDICATION 1,527
1.8%
30 NEUTROPHIL COUNT DECREASED 1,520
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.